Sativex by GW Pharmaceuticals is the first fully approved cannabis-based medicine. It is an oral spray containing THC and CBD, used in the treatment of multiple sclerosis (MS) patients. Today, Sativex is available in at least 25 countries, including Canada and many EU countries.
Although the world is showing definite progress, full cannabis legalization within a nation is an overall rarity. Georgia, the Netherlands, Mexico, South Africa,...
In Hong Kong, the FinTech Week 2021, which launched on November 1, hosted a seminar on misconceptions about cryptocurrencies titled "Crypto in 2021:...
Accelerating Tucano high-grade underground project; mining refocused on three other pits as UCS pushback postponed to mid-2022
(All dollar amounts expressed in US dollars...